While BCL6 expression is associated with the EBV latent antigens EBNA2 and LMP1, conflicting results have not provided a comprehensive explanation or detailed mechanism for EBV-mediated BCL6 degradation in B-cell lymphoma (28, –, 30). Here, PDLIM7 is linked to B-cell non-Hodgkin lymphoma.